-
Historical Archive
Geymonat case. Pani: "Behind the result, 2 years of work by Aifa and Nas"
The Director General of the Italian Medicines Agency thus commented on the investigation into the counterfeiting of the medicine Ozopulmin which led to the arrest…
Leggi » -
Historical Archive
Gb, prize for a study on a prescribing pharmacist project
While in Italy Pharmaceutical care is being tested [see below], in England it is an organizational model being…
Leggi » -
Historical Archive
After 'doctor Web' 80% patients back to the doctor to understand
Italians consult more and more the "doctor Web", but then talk to their doctor. Over two-thirds of…
Leggi » -
Historical Archive
Pharmaceutical industry. “It is worth 1.5% of GDP and over 4% of exports”
The Institute for Competitiveness has presented a research which shows that, between 2001 and 2011, the weight of the pharmaceutical…
Leggi » -
Historical Archive
'Farmamarket' investigation: filing for Zinzani and 5 other suspects
by annalisaperla June 20, 2013
Leggi » -
Historical Archive
EU fines: 93 million and 800 thousand euros for LUNDBECK
EU fines: LUNDBECK 93 million and 800 thousand euros The European Commission has fined the Danish pharmaceutical company Lundbeck for…
Leggi » -
Historical Archive
Sick abroad from October for innovative drugs at NHS expense
There is no innovative drug in Italy. In France, Germany or Austria yes. And if you currently need a permit from the…
Leggi » -
Historical Archive
-
Historical Archive
Fake drug for children, Nas: investigation born from a report from a pharmacist
It was a pharmacist in Rome who reported to the pharmacovigilance system the inadequate and suspected consistency of the drug (Ozopulmin)…
Leggi » -
Historical Archive